Large-scale testing (Phase 3)Study completedNCT04416906What this trial is testingA Test and Treat Strategy in New HIV Diagnosis.Who this might be right forHIV-1-infection Judit Pich Martínez 100
Not applicableUnknownNCT00797381What this trial is testingEfficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With HemophiliaWho this might be right forHIV InfectionHemophilia A Shanghai Public Health Clinical Center 100
Large-scale testing (Phase 3)Study completedNCT00002359What this trial is testingA Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL RegaWho this might be right forHIV Infections The Immune Response Corporation 3,000
Testing effectiveness (Phase 2)Ended earlyNCT00300573What this trial is testingRandomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIsWho this might be right forHIV InfectionsHuman Immunodeficiency Virus Incyte Corporation 250
Large-scale testing (Phase 3)Study completedNCT00708162What this trial is testingMulticenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus RaltegravirWho this might be right forHIV Infection Gilead Sciences 724
Early research (Phase 1)Study completedNCT05148754What this trial is testingAn Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy VolunteersWho this might be right forCovid19HIV-1-infection Viriom 15
Large-scale testing (Phase 3)Study completedNCT01435018What this trial is testingThree Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KSWho this might be right forHIV-1 Infection Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 334
Large-scale testing (Phase 3)Ended earlyNCT00427297What this trial is testingOptimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, KenyaWho this might be right forHIV Infections University of Washington 34
Not applicableStudy completedNCT04638686What this trial is testingREal-Life Cohort With DOlutegravir + LAmivudinaWho this might be right forHIV-1-infection Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 185
Testing effectiveness (Phase 2)Study completedNCT02212379What this trial is testingCapacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRALWho this might be right forHIV-1 Infection ANRS, Emerging Infectious Diseases 170
Not applicableStudy completedNCT03772327What this trial is testingHIV Adherence Bottle Intervention TrialWho this might be right forHIV-1-infectionAdherence, Medication Weill Medical College of Cornell University 63
Large-scale testing (Phase 3)Study completedNCT00465205What this trial is testingHSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected PersonsWho this might be right forHIV InfectionsHerpes SimplexSexually Transmitted Diseases University of Washington 20
Large-scale testing (Phase 3)Study completedNCT01792570What this trial is testingDRV/r + RPV QD: Efficacy and Toxicity ReductionWho this might be right forHuman Immunodeficiency Virus ASST Fatebenefratelli Sacco 37
Not applicableStudy completedNCT00002354What this trial is testingIndinavir Sulfate Given Together With Stavudine to HIV-Positive PatientsWho this might be right forHIV Infections Merck Sharp & Dohme LLC 540
Large-scale testing (Phase 3)WithdrawnNCT01337583What this trial is testingA Safety and Efficacy Trial of Dapivirine Vaginal Ring in AfricaWho this might be right forHIV Infections International Partnership for Microbicides, Inc.
Large-scale testing (Phase 3)Study completedNCT00044577What this trial is testingNew Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected SubjectsWho this might be right forInfection, Human Immunodeficiency Virus IHIV Infection ViiV Healthcare 166
Large-scale testing (Phase 3)Study completedNCT00021554What this trial is testingT-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV DrugsWho this might be right forHIV Infections Hoffmann-La Roche 525
Not applicableUnknownNCT05690607What this trial is testingSmall Volume Blood Testing Validity and Acceptability for HIV-1 and Hepatitis B (TINIES for BBVs)Who this might be right forHIV InfectionsHepatitis B Central and North West London NHS Foundation Trust 300
Not applicableNot Yet RecruitingNCT05222945What this trial is testingDetermine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamideWho this might be right forHIV-1-infection ANRS, Emerging Infectious Diseases 34
Early research (Phase 1)Looking for participantsNCT07392372What this trial is testingA Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIVWho this might be right forHIV -1 Infection BioNTech SE 67